38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module

3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1	Is a	General adjectival modifier	false	Inferred relationship	Existential restriction modifier
1	Is a	Number	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely oxypertine 10 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely aspirin 75 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Benzatropine 1mg tablets	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely bisoprolol fumarate 3.75 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely eplerenone 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sulfasalazine 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tolbutamide 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely morphine hydrochloride 15 milligram/1 each conventional release rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely bumetanide 1 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely calcium gluconate 25 milligram/1 gram conventional release cutaneous gel	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely cimetidine 40 milligram/1 milliliter conventional release oral suspension	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely estradiol 4 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous cream	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely gestrinone 2.5 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely bambuterol hydrochloride 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely gentamicin (as gentamicin sulfate) 15 milligram/1 milliliter conventional release eye drops	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely mianserin hydrochloride 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely boceprevir 200 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely verapamil hydrochloride 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ispaghula husk 900 milligram/1 gram granules for conventional release oral suspension	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely etodolac 300 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely naproxen 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tolazamide 500 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely cromoglicate sodium 40 milligram/1 milliliter conventional release nasal spray	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pravastatin sodium 40 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely trilostane 60 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely lamotrigine 100 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tretinoin 500 microgram/1 gram conventional release cutaneous cream	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pimozide 4 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pizotifen 500 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely maprotiline hydrochloride 25 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely tolazamide 250 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ceftazidime (as ceftazidime pentahydrate) 2 gram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely prednisolone 1 milligram/1 milliliter conventional release oral suspension	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely domperidone 30 milligram/1 each conventional release rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely diclofenac sodium 30 milligram/1 gram conventional release cutaneous gel	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sunitinib (as sunitinib malate) 50 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely xylometazoline hydrochloride 1 milligram/1 milliliter conventional release nasal drops	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely perphenazine 2 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely bicalutamide 150 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely nateglinide 60 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely haloperidol 500 microgram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely alverine citrate 120 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ethosuximide 50 milligram/1 milliliter conventional release oral solution	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely diamorphine hydrochloride 100 milligram/1 ampule powder for conventional release solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ferrous fumarate 322 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely lisdexamfetamine dimesylate 70 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely betaxolol (as betaxolol hydrochloride) 5 milligram/1 milliliter conventional release eye drops	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely vancomycin (as vancomycin hydrochloride) 1 gram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely hypromellose 10 milligram/1 milliliter conventional release eye drops	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pilocarpine hydrochloride 1 milligram/1 milliliter conventional release eye drops	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely aripiprazole 15 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye drops	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sulfinpyrazone 200 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely dinoprostone 3 milligram/1 each conventional release vaginal tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely telmisartan 20 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely levocetirizine dihydrochloride 5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely dabrafenib (as dabrafenib mesilate) 75 milligram/1 each conventional release oral capsule (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely solifenacin succinate 5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely olmesartan medoxomil 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely quinine bisulfate 300 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely podophyllotoxin 5 milligram/1 milliliter conventional release cutaneous solution	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ketorolac trometamol 5 milligram/1 milliliter conventional release eye solution	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 sachet granules for conventional release oral suspension	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely valsartan 80 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely allopurinol 300 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely carteolol hydrochloride 20 milligram/1 milliliter conventional release eye drops	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely periciazine 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely diazepam 5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely methysergide (as methysergide maleate) 1 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely carvedilol 12.5 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely conjugated estrogen 2.5 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely liothyronine sodium 20 microgram/1 ampule powder for conventional release solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely thioridazine hydrochloride 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely orlistat 60 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely hydrocortisone 5 milligram/1 gram conventional release cutaneous ointment	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ceftriaxone (as ceftriaxone sodium) 2 gram/1 vial powder for conventional release solution for injection	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely nevirapine (as nevirapine hemihydrate) 10 milligram/1 milliliter conventional release oral suspension	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pregabalin 100 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely pentazocine hydrochloride 50 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely duloxetine (as duloxetine hydrochloride) 60 milligram/1 each gastro-resistant oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely paracetamol 100 milligram/1 milliliter conventional release oral solution	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely morphine sulfate 30 milligram/1 each conventional release rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely morphine sulfate 15 milligram/1 each conventional release rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely gliclazide 80 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely amobarbital 50 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely carbamazepine 200 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely raloxifene hydrochloride 60 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ticagrelor 90 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely lercanidipine hydrochloride 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely paricalcitol 4 microgram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely ponatinib (as ponatinib hydrochloride) 45 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely fenbufen 300 milligram/1 each conventional release oral capsule	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely naproxen 500 milligram/1 each conventional release rectal suppository	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely sodium fusidate 250 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely quinine sulfate 300 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely chlorpromazine hydrochloride 10 milligram/1 each conventional release oral tablet	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier
Product containing precisely hydrotalcite 100 milligram/1 milliliter conventional release oral suspension	Count of base of active ingredient	False	1	Inferred relationship	Existential restriction modifier

Start Previous Page 298 of 342 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
3442105014	1	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module